Asthma-nefrin | Market Exclusivity | US | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Asthma-nefrin
US Exclusivities

PharmaCompass Sponsored Ads

Contact Supplier

EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

Contact Supplier

Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Contact Supplier

PharmaCompass Sponsored Ads

Contact Supplier

Aspen API. More than just an API™

Contact Supplier

jdmfs-not-supported-m-2025-04-28

Asthma-nefrin

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

39 API Suppliers, 15 USDMF, 5 CEP/COS, 3 JDMF, 3 EU WC, 20 NDC API, 15 Listed Suppliers, $ API Reference Price

39 API Suppliers
15 USDMF
5 CEP/COS
3 JDMF
3 EU WC
20 NDC API
15 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

86 Drugs in Development

86 Drugs in Development

INTERMEDIATES

3 Intermediate Suppliers

3 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

290 FDF Dossiers, 97 FDA Orange Book, 121 Europe, 19 Canada, 20 Australia, 15 South Africa, 18 Listed Dossiers

290 FDF Dossiers
97 FDA Orange Book
121 Europe
19 Canada
20 Australia
15 South Africa
18 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS - 0.15MG/DELIVERY, INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS - 0.3MG/DELIVERY, SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS - EQ 0.15MG/DELIVERY, SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS - EQ 0.1MG/DELIVERY, SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS - EQ 0.3MG/DELIVERY, SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS - EQ 1MG BASE/ML (EQ 1MG BASE/ML), SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS - EQ 30MG BASE/30ML (EQ 1MG BASE/ML), SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS - 10MG/10ML (1MG/ML), SOLUTION;INTRAVENOUS, INTRAOCULAR, INTRAMUSCULAR, SUBCUTANEOUS - 1MG/ML (1MG/ML), SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS - 30MG/30ML (1MG/ML), SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS - 0.15MG/0.3ML (0.15MG/0.3ML), SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS - 0.3MG/0.3ML (0.3MG/0.3ML), INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS - EQ 0.15MG/DELIVERY, INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS - EQ 0.3MG/DELIVERY, INJECTABLE;INJECTION - 0.005MG/ML;0.5%, INJECTABLE;INJECTION - 0.005MG/ML;1%, INJECTABLE;INJECTION - 0.005MG/ML;1.5%, INJECTABLE;INJECTION - 0.005MG/ML;2%, INJECTABLE;INJECTION - 0.01MG/ML;1%, INJECTABLE;INJECTION - 0.01MG/ML;2%, INJECTABLE;INJECTION - 0.02MG/ML;2%, INJECTABLE;INJECTION - 0.5%, INJECTABLE;INJECTION - 1%, INJECTABLE;INJECTION - 1.5%, INJECTABLE;INJECTION - 2%

INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS - 0.15MG/DELIVERY
INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS - 0.3MG/DELIVERY
SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS - EQ 0.15MG/DELIVERY
SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS - EQ 0.1MG/DELIVERY
SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS - EQ 0.3MG/DELIVERY
SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS - EQ 1MG BASE/ML (EQ 1MG BASE/ML)
SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS - EQ 30MG BASE/30ML (EQ 1MG BASE/ML)
SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS - 10MG/10ML (1MG/ML)
SOLUTION;INTRAVENOUS, INTRAOCULAR, INTRAMUSCULAR, SUBCUTANEOUS - 1MG/ML (1MG/ML)
SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS - 30MG/30ML (1MG/ML)
SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS - 0.15MG/0.3ML (0.15MG/0.3ML)
SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS - 0.3MG/0.3ML (0.3MG/0.3ML)
INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS - EQ 0.15MG/DELIVERY
INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS - EQ 0.3MG/DELIVERY
INJECTABLE;INJECTION - 0.005MG/ML;0.5%
INJECTABLE;INJECTION - 0.005MG/ML;1%
INJECTABLE;INJECTION - 0.005MG/ML;1.5%
INJECTABLE;INJECTION - 0.005MG/ML;2%
INJECTABLE;INJECTION - 0.01MG/ML;1%
INJECTABLE;INJECTION - 0.01MG/ML;2%
INJECTABLE;INJECTION - 0.02MG/ML;2%
INJECTABLE;INJECTION - 0.5%
INJECTABLE;INJECTION - 1%
INJECTABLE;INJECTION - 1.5%
INJECTABLE;INJECTION - 2%

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 9 Rochem International Inc, 19 SPI Pharma, 1 DKSH, 1 Pharm-RX Chemical, 4 Faran Shimi Pharmaceutical, 6 Boai NKY Pharmaceuticals Ltd, 7 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 2 Pfanstiehl, 1 Capital Farma, 11 Actylis, 2 Alcedo Pharmachem, 5 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Ashland, 9 BASF, 8 Beneo, 1 Bioplus Life Sciences, 2 DFE Pharma, 7 Gangwal Chemicals, 1 Huzhou Sunflower Pharmaceutical, 2 Ideal Cures Pvt Ltd, 3 Ingredion Pharma Solutions, 8 Kerry, 13 Microlex e.U, 2 Novo Excipients, 2 Pharmatrans-Sanaq, 5 Pluviaendo, 2 Prachin Chemical, 33 Roquette, 2 Seppic, 5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 2 Shijiazhuang Huaxu Pharmaceutical, 8 Sigachi Industries, 3 Silverline Chemicals, 1 Symrise, 1 Ulanqab Kema New Material, 3 Vasa Pharmachem, 3 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

68 Fillers, Diluents & Binders, 39 Taste Masking, 32 Direct Compression, 23 Disintegrants & Superdisintegrants, 22 Chewable & Orodispersible Aids, 22 Thickeners and Stabilizers, 20 Coating Systems & Additives, 17 Film Formers & Plasticizers, 16 Granulation, 14 Lubricants & Glidants, 14 Parenteral, 13 Co-Processed Excipients, 10 Controlled & Modified Release, 8 Solubilizers, 4 Topical, 4 Emulsifying Agents, 2 API Stability Enhancers, 1 Soft Gelatin, 1 Rheology Modifiers

68 Fillers, Diluents & Binders
39 Taste Masking
32 Direct Compression
23 Disintegrants & Superdisintegrants
22 Chewable & Orodispersible Aids
22 Thickeners and Stabilizers
20 Coating Systems & Additives
17 Film Formers & Plasticizers
16 Granulation
14 Lubricants & Glidants
14 Parenteral
13 Co-Processed Excipients
10 Controlled & Modified Release
8 Solubilizers
4 Topical
4 Emulsifying Agents
2 API Stability Enhancers
1 Soft Gelatin
1 Rheology Modifiers

DIGITAL CONTENT

4 Data Compilation #PharmaFlow, 1 Stock Recap #PipelineProspector, 478 News #PharmaBuzz

4 Data Compilation #PharmaFlow
1 Stock Recap #PipelineProspector
478 News #PharmaBuzz

GLOBAL SALES INFORMATION

4 US Medicaid Prescriptions, 105 Regulatory FDF Prices, 19 Annual Reports

4 US Medicaid Prescriptions
105 Regulatory FDF Prices
19 Annual Reports

MARKET PLACE

22 APIs, 26 FDF Dossiers

22 APIs
26 FDF Dossiers

PATENTS & EXCLUSIVITIES

84 US Patents, 2 US Exclusivities

84 US Patents
2 US Exclusivities

REF. STANDARDS & IMPURITIES

3 USP, 3 Others

3 USP
3 Others

$ API Ref.Price (USD/KG) : 16,628 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Name Reset all filters

2 All

01 1FRESENIUS KABI USA

02 1GLAND

filter Product Reset all filters

2 All

01 2EPINEPHRINE

filter Exclusivity Expiration Date Reset all filters

2 All

01 12025-06-03

02 12025-09-03

filter Exclusivity Code Reset all filters

2 All

01 1CGT

02 1PC

Product Main Page

FRESENIUS KABI USA

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

EPINEPHRINE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

PC

Exclusivity Expiration Date

2025-06-03

Application Number

213708

Product Number

1

Exclusivity Details

01

FRESENIUS KABI USA

BioProcess International Europe

Not Confirmed

FRESENIUS KABI USA

U.S.A

BioProcess International Europe

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

EPINEPHRINE

Exclusivity Code : PC

Exclusivity Expiration Date : 2025-06-03

Application Number : 213708

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

GLAND

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

EPINEPHRINE

Portfolio PDF

Product Web Link

Digital Content

Exclusivity Code

CGT

Exclusivity Expiration Date

2025-09-03

Application Number

219239

Product Number

1

Exclusivity Details

02

GLAND

BPI Europe

Not Confirmed

GLAND

India

BPI Europe

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

EPINEPHRINE

Exclusivity Code : CGT

Exclusivity Expiration Date : 2025-09-03

Application Number : 219239

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!